Sugi Predict

Sugi Predict / Compounds / SCHEMBL358292

SCHEMBL358292

SCHEMBL358292

N[C@@H](Cc1cc(O)c(O)c(O)c1)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 5/20 0.68
▸ SLC7A5 Q01650 5/20 0.68
▸ USP2 O75604 4/20 0.68
▸ ADORA3 P0DMS8 3/20 0.68
▸ ALOX15 P16050 3/20 0.68
▸ PTGS1 P23219 2/20 0.68
▸ PTGS2 P35354 2/20 0.68
▸ KDM4E B2RXH2 2/20 0.68
▸ RECQL P46063 2/20 0.68
▸ HIF1A Q16665 2/20 0.68
▸ TDP1 Q9NUW8 2/20 0.68
▸ EGFR P00533 1/20 0.68
▸ LCK P06239 1/20 0.68
▸ FYN P06241 1/20 0.68
▸ HTR2A P28223 1/20 0.68
▸ SIRT5 Q9NXA8 1/20 0.57
▸ PKM P14618 2/20 0.57
▸ ALPI P09923 1/20 0.57
▸ XIAP P98170 1/20 0.57
▸ THRB P10828 7/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616523 1.00 HSD17B10 (0.68) HSD17B10SLC7A5USP2ADORA3ALOX15
SCHEMBL21708950 0.89 HSD17B10 (0.60) HSD17B10SLC7A5USP2ADORA3ALOX15
SCHEMBL21708949 0.89 HSD17B10 (0.60) HSD17B10SLC7A5USP2ADORA3ALOX15
SCHEMBL5281682 0.89 SLC7A5 (0.60) HSD17B10SLC7A5USP2ADORA3ALOX15
SCHEMBL25180570 0.88 SLC7A5 (0.58) HSD17B10SLC7A5USP2ADORA3ALOX15
SCHEMBL13957567 0.88 SLC7A5 (0.58) HSD17B10SLC7A5USP2ADORA3ALOX15
SCHEMBL5302134 0.85 SLC7A5 (0.55) HSD17B10SLC7A5USP2ADORA3ALOX15
SCHEMBL296874 0.85 SLC7A5 (0.55) HSD17B10SLC7A5USP2ADORA3ALOX15
SCHEMBL296873 0.85 SLC7A5 (0.55) HSD17B10SLC7A5USP2ADORA3ALOX15
SCHEMBL9951717 0.84 SLC7A5 (0.58) HSD17B10SLC7A5USP2ADORA3ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289091-A1 POLISHING APPARATUS FOR A SUBSTRATE SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-09-18 — — US claimed
CN-117925336-A Cleaning liquid after chemical mechanical polishing and preparation method and application thereof 浙江奥首材料科技有限公司 2024-04-26 — — CN claimed
US-20230374069-A1 PEPTIDE-BASED DOPA CONTAINING ADHESIVE GELS KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2023-11-23 — — US claimed
WO-2023182763-A1 ALDEHYDE-SUBSTITUTED HYALURONIC ACID DERIVATIVE MODIFIED WITH AMINE-TERMINATED PHENOL DERIVATIVE, AND USE THEREOF 연세대학교 산학협력단 2023-09-28 — — WO claimed
CN-116726237-A Adhesive absorbable starch hemostatic microsphere and preparation method thereof 威海威高优瑞生物材料有限公司 2023-09-12 — — CN claimed
EP-4208471-A1 PEPTIDE-BASED DOPA CONTAINING ADHESIVE GELS King Abdullah University Of Science And Technology (SA) 2023-07-12 — — EP claimed
CN-113484439-B Vancomycin component structure analysis method based on two-dimensional high performance liquid chromatography-high resolution mass spectrum and vancomycin B ring-opened substance 亿腾医药(亚洲)澳门离岸商业服务有限公司 2023-06-02 — — CN claimed
CN-114344553-B Polyglutamic acid gastric acid-resistant hemostatic adhesive 南京工业大学 2022-11-25 — — CN claimed
CN-114344553-A Polyglutamic acid gastric acid-resistant hemostatic adhesive 南京工业大学 2022-04-15 — — CN claimed
WO-2022049508-A1 PEPTIDE-BASED DOPA CONTAINING ADHESIVE GELS KING ADBULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2022-03-10 — — WO claimed
US-8114654-B2 Site-specific incorporation of redox active amino acids into proteins THE SCRIPPS RESEARCH INSTITUTE (US) 2012-02-14 — — US claimed
US-8008041-B2 Site directed mutagenesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases; cells THE SCRIPPS RESEARCH INSTITUTE (US) 2011-08-30 — — US claimed
US-20110008782-A1 Site-specific incorporation of redox active amino acids into proteins THE SCRIPPS RESEARCH INSTITUTE (US) 2011-01-13 — — US claimed
CN-101532046-A Site-specific incorporation of redox active amino acids into proteins SCRIPPS RESEARCH INST 2009-09-16 — — CN claimed
EP-1687401-A4 SITE-SPECIFIC INCORPORATION OF REDOX ACTIVE AMINO ACIDS INTO PROTEINS SCRIPPS RESEARCH INST (US) 2007-08-01 — — EP claimed
CN-1942579-A Site specific incorporation of redox active amino acids into proteins SCRIPPS RESEARCH INST (US) 2007-04-04 — — CN claimed
US-20070009990-A1 Site-specific incorporation of redox active amino acids into proteins LITAL ALFONTA, ETAL 2007-01-11 — — US claimed
EP-1687401-A2 SITE-SPECIFIC INCORPORATION OF REDOX ACTIVE AMINO ACIDS INTO PROTEINS The Scripps Research Institute (US) 2006-08-09 — — EP claimed
US-20050227318-A1 Site-specific incorporation of redox active amino acids into proteins THE SCRIPPS RESEARCH INSTITUTE (US) 2005-10-13 — — US claimed
WO-2005038002-A2 SITE-SPECIFIC INCORPORATION OF REDOX ACTIVE AMINO ACIDS INTO PROTEINS THE SCRIPPS RESEARCH INSTITUTE (US) 2005-04-28 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227318-A1 Site-specific incorporation of redox active amino acids into proteins AARS1, OSGEP, EPRS1 HSD17B10 653/4885SLC7A5 569/4885USP2 1623/4885
US-20070009990-A1 Site-specific incorporation of redox active amino acids into proteins AARS1, OSGEP, EPRS1 HSD17B10 653/4885SLC7A5 569/4885USP2 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.